BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.
about
BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
BRCA1 alterations with additio ...... with neoadjuvant chemotherapy.
@en
BRCA1 alterations with additio ...... with neoadjuvant chemotherapy.
@nl
type
label
BRCA1 alterations with additio ...... with neoadjuvant chemotherapy.
@en
BRCA1 alterations with additio ...... with neoadjuvant chemotherapy.
@nl
prefLabel
BRCA1 alterations with additio ...... with neoadjuvant chemotherapy.
@en
BRCA1 alterations with additio ...... with neoadjuvant chemotherapy.
@nl
P2093
P2860
P356
P1476
BRCA1 alterations with additio ...... with neoadjuvant chemotherapy.
@en
P2093
Aiko Sato-Otsubo
Fumie Ohkubo
Hiroyuki Takei
Katsunori Tozuka
Mamoru Takada
Masafumi Kurosumi
Masaru Miyazaki
Masayuki Haruta
Ryuichi P Sugino
Seishi Ogawa
P2860
P304
P356
10.1002/GCC.22445
P577
2017-01-25T00:00:00Z